tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Progyny price target raised to $34 from $30 at BofA

BofA raised the firm’s price target on Progyny (PGNY) to $34 from $30 and keeps a Buy rating on the shares. Progyny’s Q4 results reflect improving utilization trends, which suggests softer utilization trends earlier in the year are not structural, the analyst tells investors. BofA remains optimistic on end market demand in the fertility space and Progyny’s “leading position,” the analyst added.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1